See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Popular weight-loss drugs Ozempic and Wegovy are among 15 new ...
Seniors from coast to coast will soon be hit with notices of skyrocketing Medicare Part D premiums. And there's no mystery about who's to blame. Seniors' financial pain is a direct consequence of ...
The Biden administration announced on Friday the selection of the next 15 prescription drugs that will undergo price negotiations between manufacturers and Medicare, three days before President-elect ...
7don MSN
Supreme Court hands major blow to Big Pharma's fight against Biden-era Medicare drug pricing law
The U.S. Supreme Court on Monday declined to hear a pharmaceutical industry challenge to the Medicare drug price negotiation ...
WASHINGTON -- The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million ...
Supreme Court decision not to hear pharma cases gives “strong signal” that Medicare price talks will continue.
WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...
Biden-era policies have reined in insulin prices for Medicare patients, a new study says. Roughly three out of four (75%) Medicare prescription beneficiaries were paying $35 or less for each month's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results